A normal A1C level falls below 5.7 percent. Results between 5.7 and 6.4 percent indicate prediabetes, and an A1C of 6.5 percent or higher on two separate tests is used to diagnose type 2 diabetes. Those cutoffs, established by the American Diabetes Association, are the numbers most doctors use when interpreting your results. But the test carries more nuance than a simple chart suggests, because a surprising number of conditions that have nothing to do with blood sugar can push your A1C up or down.
What the Test Actually Measures
Glucose in your bloodstream gradually attaches to hemoglobin, the oxygen-carrying protein inside red blood cells. This attachment happens continuously and without the help of enzymes, forming what is called glycated hemoglobin, specifically hemoglobin A1c. Because red blood cells live for roughly 120 days, the amount of glucose stuck to them reflects your average blood sugar over the previous two to three months rather than a single snapshot in time.1PubMed. The glycosylation of hemoglobin: relevance to diabetes mellitus The connection between elevated glycated hemoglobin and diabetes was first identified by Samuel Rahbar and colleagues in 1969, and A1C has since become the standard marker for long-term glucose management.2PubMed. Haemoglobin A1c: Historical overview and current concepts
This “rolling average” quality is what makes A1C so useful. A fasting glucose reading tells you what your blood sugar is doing right now; an A1C tells you what it has been doing for weeks. That is why doctors rely on it not just for diagnosis but for tracking whether a treatment plan is working.
Translating A1C Into Everyday Glucose Numbers
Most people check blood sugar in milligrams per deciliter on a home meter, so A1C percentages can feel abstract. A large international study established a formula that converts A1C into an estimated average glucose. The relationship is roughly linear: each one-point increase in A1C corresponds to about a 29 mg/dL increase in average blood sugar.3PubMed Central. Translating the A1C assay into estimated average glucose values In practical terms:
- A1C of 5.0 percent: roughly 97 mg/dL average glucose
- A1C of 6.0 percent: roughly 126 mg/dL
- A1C of 7.0 percent: roughly 154 mg/dL
- A1C of 8.0 percent: roughly 183 mg/dL
- A1C of 9.0 percent: roughly 212 mg/dL
These estimates help you compare what your doctor tells you with what your glucose meter shows day to day. Keep in mind that “average” smooths over swings. Two people with the same A1C can have very different daily glucose patterns: one person’s readings might hover near the average, while another’s might spike high after meals and dip low overnight, producing the same average but a much bumpier ride.
How the Test Is Done
In most hospital and reference laboratories, A1C is measured with high-performance liquid chromatography, a technique that physically separates glycated hemoglobin from other hemoglobin fractions.4PubMed. A high-performance liquid chromatography method for hemoglobin A1c Modern analyzers certified by national standardization programs can run a sample in a little over a minute with very tight precision.5Scientific Reports. Comparative analysis of enzymatic assay for HbA1c measurement with high performance liquid chromatography Immunoassay and enzymatic methods are also common, particularly in automated chemistry platforms. Different laboratories may use different techniques, but certification programs exist to make sure results are comparable across methods.6PubMed Central. Comparative evaluation of three different methods for HbA1c measurement with High-performance liquid chromatography in diabetic patients
Point-of-care devices let a doctor test your A1C from a fingerstick right in the office, delivering a result in minutes. A pooled analysis found these rapid tests correlate well with lab values, with an overall correlation coefficient of about 0.97.7PubMed Central. Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis One well-studied device showed a mean bias of less than 0.03 percent compared with the reference lab, whether fingerstick or venous blood was used.8PubMed Central. Accuracy and Precision of a Point-of-Care HbA1c Test That said, accuracy tends to be tightest in the 6 to 8 percent range, and earlier-generation monitors have occasionally produced results that could lead to a different clinical decision than the lab would.9PubMed. Comparison of point-of-care HbA1c test versus standardized laboratory testing If your doctor adjusts medication based on a point-of-care reading alone, confirming with a lab draw is reasonable, especially when the result is borderline.
When Your A1C Can Be Misleading
Because A1C depends on glucose sticking to hemoglobin over the life of a red blood cell, anything that changes how long red blood cells live or how hemoglobin behaves can skew the number independent of your actual blood sugar.
Iron deficiency is one of the most common culprits. When you are low on iron, your body produces fewer new red blood cells, meaning the ones in circulation are older on average and have accumulated more glycated hemoglobin. The result is a falsely elevated A1C. One study of iron-deficient individuals with controlled blood sugar found their A1C averaged about 6.8 percent, meaningfully higher than controls.10PubMed Central. Influence of Iron Deficiency Anemia on Hemoglobin A1C Levels in Diabetic Individuals with Controlled Plasma Glucose Levels A large retrospective analysis confirmed the pattern, showing A1C roughly 0.3 to 0.4 percentage points higher in people classified with iron deficiency anemia compared with those who had normal iron.11PubMed. Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations This matters because a prediabetes diagnosis at A1C 5.7 percent could, in someone with untreated iron deficiency, really be a normal sugar level wearing an inflated number.
The opposite effect happens in conditions that shorten red blood cell lifespan, such as hemolytic anemia or treatment with erythropoietin for chronic kidney disease. When red cells are younger on average, they have had less time to accumulate glycated hemoglobin, and A1C drops even though blood sugar has not changed. In patients with diabetes and chronic kidney disease, both intravenous iron and erythropoietin treatment caused A1C to fall significantly without any change in average blood glucose.12PubMed Central. The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease Vitamin B12 deficiency can push A1C in the opposite direction by slowing red cell production, and correcting the deficiency brings it back down.13Nephrology Dialysis Transplantation. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
Hemoglobin Variants and Genetic Factors
Hemoglobin comes in several genetic variants, and some of them can interfere with A1C measurement depending on the lab technique used. Sickle cell trait, carried by roughly 8 percent of Black Americans, is one of the better-studied cases. Research has found that the presence of hemoglobin S can create minor assay interference with common measurement methods, even when the test is certified to be unaffected.14JAMA. Association of Sickle Cell Trait With Hemoglobin A1c in African Americans Beta-thalassemia minor can be even more problematic. At least one immunoassay method has been shown to produce falsely high A1C values in people with beta-thalassemia minor, pushing results into the diabetic range in people who do not have diabetes.15Saudi Medical Journal. Effect of sickle cell trait and B-Thalassemia minor on determinations of HbA1c by an immunoassay method
If you carry a hemoglobin variant and your A1C seems inconsistent with your fingerstick readings or symptoms, your doctor may need to use a different assay method or skip A1C entirely and rely on alternative markers.
Differences by Race, Ethnicity, and Age
Even after accounting for differences in blood sugar, A1C levels are not identical across racial and ethnic groups. A study from the Diabetes Prevention Program looked at people with impaired glucose tolerance and found that, after adjusting for fasting glucose, insulin resistance, body weight, and other factors, Black participants averaged an A1C of 6.18 percent versus 5.78 percent for white participants. Hispanic, Asian, and American Indian participants fell in between.16PubMed Central. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program These gaps are not fully explained by hemoglobin variants, and researchers are still working to understand the biology behind them. The practical implication is that fixed cutoffs like 5.7 and 6.5 percent may classify people differently depending on their background.
Age also plays a role. A1C rises by about 0.1 percentage points per decade of life, independent of glucose levels.17PubMed. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes A 70-year-old with an A1C of 5.9 percent may have fundamentally normal glucose control, while the same number in a 30-year-old would suggest closer monitoring. None of the standard cutoffs account for this age drift, which means older adults are somewhat more likely to be flagged for prediabetes on the basis of A1C alone.
Pregnancy and A1C
During pregnancy, blood volume expands and red blood cell production speeds up, which means the average red cell circulating in a pregnant woman’s body is younger than usual. Younger red cells have had less time to accumulate glycated hemoglobin, so A1C tends to fall during pregnancy, particularly before 20 weeks, regardless of what blood sugar is doing.18PubMed Central. Trimester-specific reference intervals for hemoglobin A1c in non-diabetic pregnancy in a Chinese population This makes A1C less reliable for diagnosing or monitoring gestational diabetes, which is why most guidelines use an oral glucose tolerance test for pregnant patients instead.
A1C in Children and Adolescents
The standard adult A1C cutoffs were developed entirely from adult data. Research in obese children and adolescents has found that an A1C of 6.5 percent substantially underestimates both prediabetes and type 2 diabetes in younger populations when compared with glucose-based tests. One study in a large multiethnic pediatric cohort found the optimal A1C threshold for identifying type 2 diabetes was closer to 5.8 percent rather than 6.5 percent, and for identifying impaired glucose tolerance the threshold was around 5.5 percent.19Diabetes Care. Utility of Hemoglobin A1c for Diagnosing Prediabetes and Diabetes in Obese Children and Adolescents A broader review of the pediatric literature reached the same conclusion: using adult A1C cutoffs in children and teenagers significantly underestimates how many of them have prediabetes or diabetes.20Journal of Adolescent Health. Using Hemoglobin A1c for Prediabetes and Diabetes Diagnosis in Adolescents: Can Adult Recommendations Be Upheld for Pediatric Use? If you have a child with risk factors for type 2 diabetes, ask your pediatrician whether an oral glucose tolerance test would be more informative than A1C alone.
A1C Targets for People Already Living With Diabetes
If you have been diagnosed with type 2 diabetes, the goal is no longer “normal” A1C. Instead, you and your doctor work toward a personalized target that balances blood sugar control against the risks of treatment, particularly low blood sugar episodes and medication side effects. For many adults, a target below 7 percent is commonly used, but the American College of Physicians emphasizes that goals should be individualized based on your health, life expectancy, preferences, and the burden of treatment.21PubMed. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians For older adults, people in nursing homes, or those with serious chronic conditions like dementia or end-stage kidney disease, aggressively targeting a low A1C can cause more harm than benefit.
Staying within target does reduce complications. A study examining what happens when A1C remains in a target range over time found that people who spent less than 20 percent of their follow-up period within range had higher risks of both microvascular complications (like eye or kidney damage) and macrovascular complications (like heart attack or stroke) compared with those who spent 80 percent or more of their time in range.22PubMed Central. Association of hemoglobin A1c time in range with risk for diabetes complications Consistency matters as much as hitting a number on a single test.
Lowering A1C Through Exercise
Exercise is one of the most effective non-drug tools for bringing A1C down. A randomized trial found that combining aerobic exercise with resistance training produced a reduction of about 0.34 percentage points in A1C compared with a non-exercising control group. Aerobic or resistance training alone each trended toward improvement, but only the combination reached statistical significance.23PubMed Central. Effects of Aerobic and Resistance Training on Hemoglobin A1c Levels in Patients With Type 2 Diabetes A separate trial confirmed that either type of training alone can improve glucose control, but the biggest gains come from doing both.24PubMed. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial
A third of a percentage point might not sound dramatic, but in A1C terms it is clinically meaningful. It can be the difference between qualifying for an additional medication and not, or between prediabetes and a normal reading. And it stacks with dietary changes and medication effects.
How Medications Move the Number
Metformin remains the most widely prescribed first-line medication for type 2 diabetes. Newer drug classes, including SGLT2 inhibitors, have shown comparable ability to lower A1C while also promoting weight loss.25PubMed Central. Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes When metformin alone is not enough, the choice of add-on drug matters. A network meta-analysis found that GLP-1 receptor agonists produced greater A1C reductions than sulfonylureas, DPP-4 inhibitors, and several other drug classes, performing comparably to insulin.26PubMed. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis A later systematic review confirmed that insulin regimens and specific GLP-1 receptor agonists added to metformin produced the largest reductions overall.27PubMed. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
The GLP-1 class includes drugs like semaglutide and liraglutide. Their dual benefit of strong A1C reduction and weight loss has made them increasingly popular, though they come with gastrointestinal side effects and higher costs. Your doctor will weigh A1C-lowering potency against side effects, cost, and cardiovascular or kidney benefits when choosing what to add.
When A1C Is Not Enough and Alternatives Worth Knowing
For people whose A1C is unreliable due to hemoglobin variants, kidney disease, or rapid red cell turnover, other markers can fill the gap. Glycated albumin measures glucose attachment to albumin in the blood instead of hemoglobin. Because albumin turns over faster than red blood cells, glycated albumin reflects the previous two to three weeks of glucose control rather than two to three months. A study comparing several markers found that glycated albumin correlated more tightly with continuous glucose monitor readings (specifically, time spent in the target range of 70 to 180 mg/dL) than A1C did, particularly in the first eight weeks of a new treatment.28The Journal of Clinical Endocrinology & Metabolism. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine
Fructosamine is another alternative that reflects glycation of serum proteins over a similar short window. It is useful when A1C is unreliable, but it has its own vulnerabilities. In one case report, a patient with sickle cell disease and a separate protein disorder had a persistently elevated fructosamine despite continuous glucose monitor data showing near-perfect glucose control. The elevated protein from monoclonal gammopathy was giving extra glycation sites, falsely inflating the reading. A glycated albumin level and continuous glucose monitoring both confirmed the patient’s sugar was fine.29Journal of the Endocrine Society. 5176 Time In Range Preferred Over A1c And Fructosamine To Monitor Glycemic Control In Sickle Cell Disease Continuous glucose monitors are increasingly used not just by people with diabetes but as a diagnostic check in complex cases where every blood marker has a potential blind spot.
Screening and Catching Problems Early
The convenience of A1C as a screening tool is hard to overstate. Unlike fasting glucose, it does not require you to skip breakfast. Unlike an oral glucose tolerance test, it takes minutes rather than hours. Systematic reviews of diabetes screening programs have consistently found them to be cost-effective, though the optimal age to start and how often to repeat the test vary by setting.30PubMed Central. Cost effectiveness of type 2 diabetes screening: A systematic review In the United States, current guidelines recommend screening starting at age 35 for all adults, or earlier if you have risk factors like obesity, a family history of diabetes, or a history of gestational diabetes.
A1C also shows up in unexpected clinical contexts. Some surgical teams now order it before joint replacement surgery to check for undiagnosed or poorly controlled diabetes, because elevated blood sugar increases infection risk. An analysis of routine A1C screening before hip and knee replacement found that it saved money overall when used before hip replacement in people already known to have diabetes, where roughly 286 patients needed to be screened to prevent one prosthetic joint infection. The cost-benefit balance was less favorable in other scenarios, including screening patients with no diabetes history before knee replacement.31PubMed Central. Costs and benefits of routine hemoglobin A1c screening prior to total joint arthroplasty: a cost-benefit analysis The broader point is that A1C has grown far beyond its original role in diabetes clinics and now influences decisions across medicine.